Cellulitis

What Is Cellulitis?
How Cellulitis Develops
Recognizing Cellulitis: Symptoms and Signs
Differential Diagnosis
Treatment: Antibiotics
Recurrent Cellulitis: Prevention
Complications
Special Situations
Natural Supportive Measures and Wound Care
References & Research
Connections
Featured Videos

What Is Cellulitis?

Cellulitis is a common bacterial skin infection that affects the deep layers of the skin — specifically the dermis (the thick inner layer) and the subcutaneous fat beneath it. Unlike superficial skin infections, cellulitis penetrates deeply into tissue and can spread rapidly if not treated promptly.

Cellulitis is one of the most common skin infections seen in emergency departments and primary care offices in the United States, accounting for approximately 14 million cases per year. It can affect anyone at any age, though certain risk factors — particularly poor circulation, diabetes, and lymphedema — dramatically increase susceptibility.

The infection is caused predominantly by two types of bacteria:

Group A Streptococcus (Streptococcus pyogenes) — the most common cause of lower-leg cellulitis
Staphylococcus aureus — including methicillin-resistant S. aureus (MRSA) in approximately 10% of cases

Bacteria enter the skin through breaks in the barrier — cuts, abrasions, insect bites, athlete's foot between the toes, surgical wounds, venous ulcers, or the cracked skin of lymphedema. The lower leg is the most common site of infection, though cellulitis can occur anywhere on the body.

Recognizing cellulitis early and treating it with the right antibiotics is essential. Left untreated, it can progress to serious complications including blood poisoning (sepsis), permanent lymphatic damage, and in rare emergencies, the life-threatening infection called necrotizing fasciitis.

How Cellulitis Develops

Understanding how cellulitis takes hold helps explain why certain people are far more vulnerable than others — and why preventing the entry point matters as much as treating the infection itself.

The Entry Point: Skin Barrier Breach

Healthy skin is a remarkable barrier. It has layers of tightly packed cells, oils, and immune defenses that keep bacteria out. When that barrier is broken — even by something as minor as a small cut, a cracked heel, or the peeling skin between the toes from athlete's foot — bacteria gain access to the deeper tissue below.

Athlete's foot (tinea pedis) is the single most common entry point for leg cellulitis. The fungal infection causes the skin between the toes to crack and peel, creating an open doorway for streptococcal bacteria. This is why treating athlete's foot is considered the most important preventive measure for recurrent leg cellulitis.

The Inflammatory Cascade

Once bacteria enter the dermis and subcutaneous fat, the immune system launches an inflammatory response. Key inflammatory signals — including interleukin-1 beta (IL-1β), tumor necrosis factor-alpha (TNF-α), and interleukin-6 (IL-6) — flood the area. This cascade produces the hallmark signs of infection: redness, warmth, swelling, and pain.

The infection does not stay neatly contained. Without treatment, bacteria and their toxins spread through the tissue planes, causing the characteristic expanding border of redness seen in cellulitis.

Lymphatic Involvement

In about 5% of cases, the infection spreads into the lymphatic vessels — the small channels that drain fluid from tissues back to the bloodstream. When this happens, you can see red streaks tracking up the limb from the infected area, a condition called lymphangitis. These streaks are a warning sign that the infection is advancing and requires urgent treatment.

Risk Factors That Open the Door

Several conditions make cellulitis far more likely to develop or recur:

Lymphedema — chronic swelling from impaired lymph drainage disrupts skin integrity and impairs immune surveillance; recurrence rate reaches 45% per year in people with lymphedema
Obesity — disrupted lymphatic drainage and skin folds create warm, moist environments where bacteria thrive
Venous insufficiency — chronic leg swelling, skin changes, and venous ulcers provide constant entry points
Diabetes — impaired immune function and peripheral neuropathy (reduced sensation) mean that small wounds often go unnoticed until infected
Prior cellulitis — each episode causes some degree of permanent lymphatic scarring, raising the risk of the next episode
Tinea pedis (athlete's foot) — the most preventable risk factor for leg cellulitis
Intravenous drug use — injection sites provide direct bacterial access
Immunosuppression — chemotherapy, HIV, organ transplant medications, and corticosteroids all impair the immune defenses that would otherwise contain bacterial spread

When Cellulitis Becomes an Emergency

In rare but serious cases, bacteria invade the fascial planes — the tough fibrous sheets that surround muscles. This produces necrotizing fasciitis, a rapidly spreading, flesh-destroying infection with a mortality rate of 20–30% even with surgery. Warning signs include pain that seems far worse than the skin appearance would suggest, skin turning dark or blistering, and a crunching sensation under the skin (from gas-producing bacteria). This is a surgical emergency.

Recognizing Cellulitis: Symptoms and Signs

Cellulitis usually announces itself clearly — but knowing the specific features helps distinguish it from the many other conditions that can look similar.

The Classic Signs

Medical textbooks describe the classic signs of inflammation with Latin terms that map exactly onto what you see and feel with cellulitis:

Rubor — redness of the skin
Calor — warmth; the infected skin feels noticeably hotter than surrounding areas
Tumor — swelling; the tissue becomes puffy and tense
Dolor — pain and tenderness to touch

The border of cellulitis is typically well-defined but flat — you can see where the redness ends, but the edge is not raised above the surrounding skin. This flat border distinguishes cellulitis from erysipelas (a more superficial streptococcal infection with a sharply raised, clearly elevated border).

Systemic Symptoms

About 25% of people with cellulitis develop systemic symptoms — signs that the infection is stressing the whole body, not just the local skin:

Fever and chills
Malaise (general fatigue and feeling unwell)
Rapid heart rate in more severe cases

Severity Classification

Doctors use a four-class system (developed by Eron and colleagues) to guide treatment decisions:

Class I — no fever, no systemic symptoms, no significant comorbidities; safe to treat at home with oral antibiotics
Class II — systemic symptoms present (fever, elevated white cell count) OR significant comorbid disease (diabetes, venous insufficiency, obesity) but the patient is not critically ill; may need oral or intravenous antibiotics, sometimes with brief hospital observation
Class III — systemic sepsis (high fever, very rapid heart rate, low blood pressure, confusion) OR a limb-threatening infection; hospitalization and intravenous antibiotics required
Class IV — life-threatening infection including necrotizing fasciitis; surgical emergency requiring immediate debridement

The Sharpie Test: Tracking Spread

One of the most useful practical tools for monitoring cellulitis is embarrassingly simple: a felt-tip pen (like a Sharpie). At the first medical evaluation, a clinician draws a line around the outer border of the redness. If the redness has spread beyond the line at the next check (typically 24–48 hours later), the infection is not responding to treatment. If the redness is contained within or receding from the line, the antibiotics are working. This simple technique — sometimes called the "pen test" or demarcation technique — gives an objective, easy-to-read measure of response.

A Critical Point About Bilateral Leg Swelling

If both legs appear red and swollen at the same time, cellulitis is almost certainly not the diagnosis. A landmark study by Lee and colleagues (2015) found that more than 85% of patients presenting with apparent bilateral leg "cellulitis" actually had stasis dermatitis combined with venous edema — a chronic, non-infectious condition caused by poor venous circulation. True bilateral simultaneous cellulitis is extraordinarily rare. Treating stasis dermatitis with antibiotics delays proper care and contributes to antibiotic resistance.

Differential Diagnosis

Cellulitis is one of the most commonly misdiagnosed conditions in medicine. Studies suggest that 20–30% of patients admitted to hospital for "cellulitis" actually have a different condition. Getting this right matters enormously — unnecessary antibiotic courses have real costs and risks.

Stasis Dermatitis

The most common masquerader. Caused by chronic venous insufficiency, stasis dermatitis produces redness, warmth, and swelling of the lower legs — often both legs simultaneously. Key distinguishing features: it is chronic (present for weeks or months, not sudden onset), bilateral in most cases, associated with brown discoloration from iron deposits (hemosiderin staining) from leaking blood vessels, and there is no fever. Treatment is compression stockings and leg elevation — not antibiotics.

Deep Vein Thrombosis (DVT)

A blood clot in the deep leg veins causes swelling, redness, and tenderness that can look identical to cellulitis. DVT typically lacks the warmth and spreading quality of cellulitis, and there is usually no fever or lymphangitis. A Doppler ultrasound of the leg veins is the diagnostic test of choice. DVT requires anticoagulation, not antibiotics.

Gout

Acute gout — a sudden attack of uric acid crystal deposition — produces explosive joint redness, warmth, and swelling that is often mistaken for cellulitis overlying a joint. Key clues: the inflammation is centered on a joint (especially the big toe or ankle), there may be visible tophi (uric acid deposits), and serum uric acid is often elevated. Joint fluid analysis showing needle-shaped crystals under polarized light confirms the diagnosis.

Contact Dermatitis

An allergic or irritant reaction to a substance touching the skin. Contact dermatitis tends to produce itching more than pain, and the distribution typically follows the shape of the allergen contact (for example, the outline of a watchband or a patch). There is no fever. A careful history about recent exposures is key.

Lipodermatosclerosis

A chronic fibrotic change in the skin and fat of the lower legs caused by long-standing venous disease. It produces hardened, indurated, reddish-brown skin — particularly above the ankle — that can look inflamed but is not infectious. The classic description is an "inverted champagne bottle" appearance: the ankle becomes narrow and fibrotic while the calf swells above it.

Erysipelas

A more superficial streptococcal skin infection that is closely related to cellulitis. The distinguishing feature of erysipelas is its raised, sharply demarcated border — you can feel the edge of the infection as a ridge. The skin has a shiny, orange-peel (peau d'orange) texture. Erysipelas most commonly affects the face or lower leg and is caused almost exclusively by Group A Streptococcus.

Necrotizing Fasciitis

The most dangerous diagnosis to miss. Necrotizing fasciitis initially looks like severe cellulitis, but the pain is disproportionately severe relative to the skin changes. Over hours, the skin may develop dark purple discoloration, blistering, or areas of necrosis. A crunching sensation (crepitus) may be felt under the skin from gas-producing bacteria. CT scan can show gas tracking along the fascial planes. Surgeons use the "finger test" in the operating room — if a finger inserted through a small incision meets no resistance and the tissue separates without bleeding, necrotizing fasciitis is confirmed. This requires immediate surgical debridement. Every hour of delay significantly worsens survival.

Treatment: Antibiotics

Cellulitis requires antibiotic treatment. Unlike some bacterial infections that may resolve on their own, cellulitis in the dermis and subcutaneous fat will generally progress without antibiotics. The choice of antibiotic depends on severity, the likely organism, and whether MRSA is a concern.

Outpatient Treatment (Mild Cellulitis — Class I)

For cellulitis without systemic symptoms and without significant comorbidities, oral antibiotics at home are appropriate and effective.

First-line (covering Group A Strep and MSSA):

Cephalexin 500 mg four times daily for 5–7 days — the IDSA first-line recommendation for uncomplicated cellulitis
Dicloxacillin 500 mg four times daily (must be taken on an empty stomach)
Amoxicillin-clavulanate (Augmentin) — covers a broader spectrum including some gram-negatives, useful for bite wounds or perirectal infections

When MRSA is suspected (prior MRSA infection, failed initial therapy, visible pustules or abscess, intravenous drug use, or known MRSA carrier status), coverage must specifically target MRSA:

Trimethoprim-sulfamethoxazole (TMP-SMX) 1–2 double-strength tablets twice daily, combined with amoxicillin or cephalexin (TMP-SMX alone has poor coverage for Group A Streptococcus, which is still a common cause of cellulitis)
Doxycycline 100 mg twice daily — covers both MRSA and Group A Strep in many cases
Clindamycin 300–450 mg three times daily — effective against MRSA and Strep; check local resistance rates before using

Inpatient Treatment (Moderate to Severe — Class II/III)

When cellulitis is accompanied by systemic signs of infection, spreading rapidly, or not responding to oral antibiotics, intravenous antibiotics in hospital are needed.

Nafcillin or oxacillin 1–2 g intravenously every 4–6 hours — first-line for methicillin-sensitive S. aureus (MSSA); superior to vancomycin for MSSA
Vancomycin intravenously at 15–20 mg/kg every 8–12 hours — the standard of care for confirmed or suspected MRSA, or when the patient is severely ill pending culture results
Daptomycin 4 mg/kg intravenously once daily — an alternative for MRSA that is particularly useful when vancomycin cannot be tolerated
Linezolid — reserved for complex MRSA cases; significant drug interactions and cost

Switching from IV to Oral

Inpatient patients can typically step down to oral antibiotics once they have been fever-free for 24–48 hours and the area of redness is clearly receding. Early step-down is actively encouraged — it reduces hospital costs, complication risk, and length of stay with no loss of effectiveness.

Duration of Treatment

A landmark clinical trial by Hepburn and colleagues demonstrated that 5 days of treatment is non-inferior to 10 days for uncomplicated cellulitis in otherwise healthy patients. The current IDSA Skin and Soft Tissue Infection guidelines (2014) reflect this: 5 days is the recommended minimum, extending to 14 days only if the infection is slow to respond.

One important note: gram-negative bacteria do not need to be covered in typical cellulitis. Antibiotics targeting gram-negative organisms (like fluoroquinolones or extended-spectrum beta-lactams) are not needed unless the infection involves a bite wound, water exposure, a perirectal location, or the patient is severely immunocompromised (neutropenic).

Recurrent Cellulitis: Prevention

Without addressing the underlying risk factors, cellulitis comes back. Studies show a 45% recurrence rate within 3 years in patients who have had one episode. For people with lymphedema, the annual recurrence rate reaches 45%. Prevention is therefore a central part of cellulitis management — not an afterthought.

Tier 1: Address the Entry Point

The single most effective intervention for preventing recurrent leg cellulitis is treating athlete's foot (tinea pedis). Fungal infections between the toes create exactly the kind of small, moist skin cracks that streptococcal bacteria use to enter the tissue.

Terbinafine cream 1% applied once daily for 4 weeks — effective for most tinea pedis
Oral terbinafine 250 mg daily for 2–6 weeks — for more extensive or recurrent fungal infections
Clotrimazole or miconazole cream — available without prescription; apply twice daily for 4 weeks

Beyond athlete's foot, basic skin maintenance prevents many recurrences:

Moisturize daily — use an unscented emollient on legs and feet to prevent skin cracking, especially in people with dry skin or eczema
Cover all skin breaks promptly — even small cuts and abrasions should be cleaned and covered until healed
Inspect feet daily — especially if you have diabetes or peripheral neuropathy and may not feel small wounds

Tier 2: Manage Underlying Conditions

Compression stockings for lymphedema and chronic venous insufficiency — reducing leg swelling directly reduces skin fragility and the risk of breakdown
Weight management — obesity impairs lymphatic drainage and increases skin fold risk; even modest weight loss improves outcomes
Wound care for chronic leg ulcers — venous ulcers that are properly dressed and managed are less likely to serve as persistent bacterial entry points

Prophylactic Antibiotics for Frequent Recurrences

For patients who have had two or more episodes of cellulitis per year despite attention to the above measures, long-term prophylactic antibiotics are recommended. The landmark PATCH trial (Thomas et al., New England Journal of Medicine, 2013) demonstrated that prophylactic penicillin reduced the recurrence rate by 45% relative risk reduction compared to placebo.

Prophylaxis options include:

Penicillin V 250 mg twice daily — the regimen studied in the PATCH trial; preferred first-line
Phenoxymethylpenicillin 250 mg twice daily for 6–12 months
Erythromycin 250 mg twice daily — for penicillin-allergic patients
Azithromycin 500 mg once weekly — an alternative for those who struggle with daily dosing

Important caveats: prophylaxis only works while you are taking it. The recurrence rate returns to baseline when antibiotics are stopped. This is a shared decision with your doctor, weighing the burden of frequent infections against the modest risks of long-term antibiotic use.

Complications

Most cases of cellulitis treated promptly with appropriate antibiotics resolve completely within 1–2 weeks. However, delayed treatment, inadequate therapy, or underlying conditions that impair healing can lead to serious complications.

Local Complications

Abscess formation — bacteria may wall off into a pus-filled pocket. Abscesses require incision and drainage (I&D) in addition to antibiotics; antibiotics alone cannot penetrate the abscess cavity effectively. Wound cultures from drained abscesses help identify the causative organism and guide antibiotic choice
Lymphangitis — infection spreading into lymphatic channels, visible as red streaks tracking from the infected area; indicates advancing infection requiring urgent treatment
Thrombophlebitis — inflammation and clotting in superficial veins near the infected area
Lymphatic damage — even a single episode of cellulitis can scar the delicate lymphatic vessels in the affected limb, contributing to post-infection swelling that may become permanent
Osteomyelitis — infection reaching underlying bone, particularly when cellulitis occurs directly over a bone or in a diabetic foot; requires prolonged antibiotic therapy and sometimes surgical debridement

Systemic Complications

Bacteremia — bacteria entering the bloodstream; occurs in 3–4% of cellulitis cases overall, rising significantly with lymphedema or immunosuppression; blood cultures are positive in only about 2–4% of routine cases but are essential in severe or septic presentations
Sepsis — the systemic inflammatory response to infection, with organ dysfunction; occurs in 1–3% of cellulitis hospitalizations and carries significant mortality risk
Endocarditis and septic arthritis — hematogenous seeding of MRSA to heart valves or joints during bacteremia; rare but life-threatening
Post-streptococcal glomerulonephritis — an immune-mediated kidney inflammation that can follow Group A Streptococcal infection; rare complication of streptococcal cellulitis

The Chronic Vicious Cycle

Perhaps the most insidious long-term complication is post-cellulitis lymphedema. Recurrent episodes of cellulitis progressively damage the lymphatic channels of the affected limb. This damage produces permanent lymphedema — chronic swelling that impairs skin integrity, which in turn makes the skin more susceptible to further bacterial entry, triggering more cellulitis episodes, which cause more lymphatic damage. Breaking this cycle requires aggressive management of both the recurrent infections and the underlying lymphedema.

Special Situations

Diabetic Foot Cellulitis

Foot infections in people with diabetes deserve special attention because they are frequently polymicrobial (caused by multiple bacteria simultaneously, including gram-negative rods and anaerobes in addition to the usual streptococci and staphylococci) and they carry a high risk of progressing to bone infection (osteomyelitis).

Key features of diabetic foot assessment:

The probe-to-bone test — a blunt metal probe inserted into a wound that reaches bone has a sensitivity of 89% for underlying osteomyelitis
MRI of the foot is the most sensitive imaging test for osteomyelitis
Empiric antibiotics must cover a broader spectrum: amoxicillin-clavulanate for mild infections; piperacillin-tazobactam or a carbapenem for severe infections
Vascular surgery assessment is essential — impaired blood flow dramatically reduces antibiotic delivery and healing capacity

Orbital and Periorbital Cellulitis

Cellulitis around the eye requires immediate evaluation to determine whether the infection is in front of or behind the orbital septum (the fibrous sheet that separates the eyelid from the orbit):

Preseptal (periorbital) cellulitis — infection confined to the eyelid in front of the orbital septum; no proptosis (eye bulging), no pain with eye movement; usually treated safely with oral antibiotics
Orbital cellulitis — infection behind the orbital septum, involving the fat and muscles around the eyeball; produces proptosis, restricted and painful eye movements, fever, and can cause vision loss or spread to the brain; requires urgent CT scan, intravenous antibiotics, and ophthalmology/ENT consultation

Facial Cellulitis

The face is a higher-risk location for cellulitis because the venous drainage runs toward the brain through valveless veins. Facial cellulitis is most commonly caused by staphylococci and streptococci. In children, Haemophilus influenzae type b historically caused distinctive violaceous (purplish) facial cellulitis — vaccination has made this rare. Buccal cellulitis (cheek cellulitis) in young children warrants blood cultures given the risk of bacteremia.

Cellulitis in Immunocompromised Patients

When a person's immune system is suppressed — by chemotherapy, HIV, organ transplant medications, or high-dose corticosteroids — unusual organisms that healthy immune systems contain without difficulty can cause severe skin infections:

Aeromonas hydrophila — after freshwater exposure (swimming in lakes, rivers; flooding injuries); causes aggressive, rapidly spreading cellulitis; requires fluoroquinolones or TMP-SMX
Vibrio vulnificus — after saltwater or seawater exposure combined with eating raw shellfish (especially oysters) in patients with liver disease; produces hemorrhagic bullae (blood-filled blisters) and is frequently fatal without immediate treatment; requires ceftriaxone plus doxycycline
Pseudomonas aeruginosa — particularly in neutropenic patients; requires antipseudomonal beta-lactam antibiotics
Fungal infections — disseminated candida or mold infections can seed the skin hematogenously in severely immunocompromised patients; antifungal therapy required

Natural Supportive Measures and Wound Care

Important note: Cellulitis is a bacterial infection that requires prescription antibiotics. The measures below are adjuncts — they support healing and comfort alongside antibiotic treatment, not instead of it. Delaying antibiotics in favor of natural remedies alone risks serious complications. If you see red streaks, develop a fever, or the infection is spreading, seek medical care immediately.

Elevation — The Most Evidence-Based Supportive Measure

Elevating the infected limb above heart level is the single most effective non-antibiotic intervention. Elevation reduces edema (swelling) by improving lymphatic return and reducing hydrostatic pressure in the veins. Many patients report dramatic pain relief within hours of consistent elevation. The IDSA Skin and Soft Tissue Infection guidelines explicitly recommend elevation as part of standard cellulitis management.

For leg cellulitis: lie with the leg propped on pillows above hip level
Aim for as much elevation time as practical — several hours per day makes a meaningful difference

Warm Compresses

Applying a clean warm (not hot) compress to the area several times daily increases local blood flow, which improves immune cell delivery and may modestly reduce pain. Warmth should be comfortable — avoid heat that could burn already-compromised skin.

Wound Care at the Entry Point

If there is a visible wound, proper care reduces bacterial load at the entry site and supports healing:

Clean the wound gently with saline or clean water
Apply a non-adherent sterile dressing, changed daily or when soiled
Manuka honey dressings have genuine evidence for reducing bacterial load in wounds and ulcers. Manuka honey from New Zealand contains methylglyoxal, which has antimicrobial properties; it may reduce bacterial colonization at wound edges

Topical Antiseptic Support

Tea tree oil (from Melaleuca alternifolia) has documented antiseptic properties and can be applied diluted (5% in carrier oil) to intact skin around — not inside — wounds to reduce surface bacterial load. Never apply undiluted tea tree oil to open wounds; it can be irritating

Anti-Inflammatory Nutritional Support

Turmeric (curcumin) — well-studied for anti-inflammatory properties; may support skin healing as an adjunct; 500–1000 mg curcumin extract standardized to 95% curcuminoids, taken with black pepper (piperine) for absorption
Vitamin C — essential for collagen synthesis (the structural protein that rebuilds skin) and immune cell function; adequate intake supports wound healing; 500–1000 mg daily is a reasonable adjunct dose
Zinc — plays a central role in skin healing and immune function; zinc deficiency impairs wound closure; dietary sources include meat, shellfish, legumes, and seeds; supplemental zinc gluconate 25–50 mg daily if deficient
Adequate protein — the body uses protein to rebuild damaged tissue; prioritize lean meat, fish, eggs, legumes, and dairy during recovery

What to Avoid

Do not squeeze, lance, or try to drain cellulitis yourself — unlike an abscess, cellulitis has no pocket to drain; squeezing can push bacteria deeper or introduce new contamination
Do not delay care if red streaks appear (lymphangitis) or if the redness spreads rapidly; these are signs of advancing infection
Do not rely on topical measures alone for a spreading infection — no cream or compress can sterilize infected deep tissue layers

References & Research

Eron LJ, et al. 2003: Managing skin and soft tissue infections: expert panel recommendations on key decision points. Journal of Antimicrobial Chemotherapy. PMID: 14523758
Thomas KS, et al. 2013: Penicillin to prevent recurrent leg cellulitis (PATCH II): a multicentre, open-label, randomised controlled trial. New England Journal of Medicine. PMID: 23915011
Hepburn MJ, et al. 2004: Comparison of short-course (5 days) and standard (10 days) treatment for uncomplicated cellulitis. Archives of Internal Medicine. PMID: 15585578
Lee CY, et al. 2015: Bilateral lower extremity cellulitis: a diagnostic dilemma. Journal of the American Board of Family Medicine. PMID: 25522022
Stevens DL, et al. 2014: Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clinical Infectious Diseases. PMID: 25114026
Kamath P, et al. 2019: Tinea pedis as a risk factor for cellulitis: a case-control study. British Journal of Dermatology. PMID: 30882139
McNamara DR, et al. 2007: Incidence of MRSA skin and soft tissue infections in a primary care setting. Journal of General Internal Medicine. PMID: 17764691
Raff AB, Kroshinsky D. 2019: Cellulitis: a review. JAMA. PMID: 31538565
Pulia MS, et al. 2018: Necrotizing soft-tissue infections. New England Journal of Medicine. PMID: 30074398
Swartz MN. 2004: Clinical practice. Cellulitis. New England Journal of Medicine. PMID: 15548782

Connections

Back to Table of Contents